We are live on
!
Find out more
MAP
Moody Aldrich Partners Portfolio holdings
AUM
$557M
1-Year Est. Return
122.79%
This Fund
S&P 500
This Quarter
Est. Return
+0.93%
1 Year Est. Return
+122.79%
3 Year Est. Return
+335.86%
5 Year Est. Return
+437.05%
10 Year Est. Return
+2,951.39%
AUM
$528M
AUM Growth
+$13M
(+2.5%)
Cap. Flow
+$23.8M
Cap. Flow
% of AUM
4.5%
Top 10 Holdings %
Top 10 Hldgs %
19.23%
Holding
222
New
70
Increased
61
Reduced
51
Closed
30
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PR
Permian Resources
PR
|
+$8.53M |
| 2 |
ArcBest
ARCB
|
+$6.03M |
| 3 |
Vaxcyte
PCVX
|
+$5.7M |
| 4 |
MZTI
The Marzetti Company
MZTI
|
+$5.23M |
| 5 |
DO
Diamond Offshore Drilling, Inc.
DO
|
+$5.05M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Green Plains
GPRE
|
+$6.34M |
| 2 |
CONMED
CNMD
|
+$5.27M |
| 3 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
+$5.25M |
| 4 |
BWX Technologies
BWXT
|
+$4.86M |
| 5 |
Terex
TEX
|
+$3.95M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.44% |
| 2 | Industrials | 14.99% |
| 3 | Financials | 14.57% |
| 4 | Technology | 13.45% |
| 5 | Energy | 10.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
UnitedHealth
UNH
$370B
| $581K | 0.11% |
+1,138
| New | +$560K |
|
127
Neurocrine Biosciences
NBIX
$16.6B
| $547K | 0.1% |
+4,863
| New | +$512K |
|
128
BioMarin Pharmaceuticals
BMRN
$12.4B
| $501K | 0.09% |
+5,657
| New | +$503K |
|
129
Steris
STE
$23.1B
| $487K | 0.09% |
2,220
+60
| +3% | +$13.6K |
|
130
Stryker
SYK
$130B
| $483K | 0.09% |
+1,775
| New | +$509K |
|
131
United Therapeutics
UTHR
$23.1B
| $457K | 0.09% |
+2,024
| New | +$466K |
|
132
Diamondback Energy
FANG
$52.7B
| $454K | 0.09% |
+2,932
| New | +$433K |
|
133
Gilead Sciences
GILD
$165B
| $439K | 0.08% |
+5,858
| New | +$451K |
|
134
Incyte
INCY
$24.4B
| $426K | 0.08% |
+7,371
| New | +$465K |
|
135
East-West Bancorp
EWBC
$18B
| $425K | 0.08% |
8,072
-179
| -2% | -$10.1K |
|
136
Amazon
AMZN
$2.96T
| $418K | 0.08% |
+3,274
| New | +$439K |
|
137
Boston Scientific
BSX
$71.5B
| $411K | 0.08% |
+7,801
| New | +$409K |
|
138
Teledyne Technologies
TDY
$32B
| $409K | 0.08% |
1,002
-22
| -2% | -$8.93K |
|
139
IQVIA
IQV
$39.3B
| $405K | 0.08% |
+2,049
| New | +$445K |
|
140
Alnylam Pharmaceuticals
ALNY
$29.3B
| $404K | 0.08% |
+2,283
| New | +$436K |
|
141
Celldex Therapeutics
CLDX
$3.28B
| $404K | 0.08% |
+14,687
| New | +$460K |
|
142
Blackstone
BX
$110B
| $388K | 0.07% |
+3,657
| New | +$381K |
|
143
Alphabet (Google) Class A
GOOGL
$4.33T
| $384K | 0.07% |
+2,874
| New | +$372K |
|
144
JPMorgan Chase
JPM
$950B
| $383K | 0.07% |
+2,641
| New | +$396K |
|
|
SF
145
Stifel
SF
$12.6B
| $380K | 0.07% |
9,267
-206
| -2% | -$8.68K |
|
146
Jones Lang LaSalle
JLL
$16.7B
| $376K | 0.07% |
2,665
+351
| +15% | +$57.3K |
|
|
KRTX
147
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $374K | 0.07% |
2,212
-7,215
| -77% | -$1.36M |
|
|
EXAS
148
DELISTED
Exact Sciences
EXAS
| $374K | 0.07% |
+5,481
| New | +$465K |
|
149
Pool Corp
POOL
$7.5B
| $373K | 0.07% |
1,048
-25
| -2% | -$9.1K |
|
150
Broadridge
BR
$19B
| $372K | 0.07% |
2,071
+358
| +21% | +$63.4K |
|
Similar funds
CAM
QL
TCM
CFP
TC
DIM
NCA
CA
Moody Aldrich Partners's Q3 2023 Portfolio in Review
As of Q3 2023, Moody Aldrich Partners held 222 positions worth $528M, up 2.5% from $515M the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Moody Aldrich Partners deployed $23.8M of net new capital in Q3 2023, opening 70 new positions and adding to 61 existing holdings. Its largest new stake was Permian Resources: 678,511 shares worth $9.47M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was BWX Technologies, an estimated $4.86M trimmed.
- Moody Aldrich Partners's largest Q3 2023 buy was Permian Resources: 678,511 shares worth $9.47M.
- Moody Aldrich Partners added most to Vaxcyte in Q3 2023, an estimated $5.7M increase.
- Moody Aldrich Partners's biggest Q3 2023 reduction was BWX Technologies, cutting an estimated $4.86M.
- Moody Aldrich Partners fully exited Green Plains in Q3 2023, selling an estimated $6.34M.
- Moody Aldrich Partners's ten largest holdings make up 19% of its $528M portfolio in Q3 2023.
- Moody Aldrich Partners opened 70 new positions and closed 30 in Q3 2023.
- Moody Aldrich Partners's portfolio value rose 2.5% quarter-over-quarter to $528M.
Based on Moody Aldrich Partners's 13F filing for Q3 2023, filed 8 Nov 2023.